Compare Abeona Therapeutics Inc (ABEO) vs Wix.Com Ltd (WIX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Wix.Com Ltd — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Wix.Com Ltd trades at $47.6 (market cap $2.11B). The key difference: Wix.Com Ltd is far larger — about 5.7× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals.
| ABEO | WIX | |
|---|---|---|
Market Cap | $373.32M | $2.11B |
Sector | Health | Technology |
52-Week High | $7.23 | $184.24 |
52-Week Low | $4.17 | $40.43 |
Enterprise Value | $228.22M | $1.67B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
WIX trades at $50.36, up 2.05% today, amid mixed signals. The stock shows strong revenue growth, reaching $1.99B in 2025, but profitability remains inconsistent with a net margin of -1.97%. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026. Technical indicators are bullish overall, with RSI suggesting mild overbought conditions. Positive news includes partnerships with Elavon and Microsoft, though legal investigations pose headwinds.
Outlook: Analyst consensus is bullish with a $83.13 price target, but risks include legal scrutiny and volatile earnings. Investment opportunity lies in revenue growth and strategic partnerships, countered by profitability challenges and potential legal liabilities. Near-term performance hinges on Q2 2026 earnings and resolution of investigations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
